Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Total Assets

Rigel Pharmaceuticals Total Assets Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Total Assets from 2010 to 2020.
  • Rigel Pharmaceuticals Total Assets for the quarter ending September 09, 2020 was $123m a -19.92% decrease of -25m year over year
  • Rigel Pharmaceuticals Total Assets for the last 12 months ending September 09, 2020 was $123m a -19.92% decrease of -25m year over year
  • Rigel Pharmaceuticals Annual Total Assets for 2019 was $148m a 5.73% increase of 8m from 2018
  • Rigel Pharmaceuticals Annual Total Assets for 2018 was $139m a 14.38% increase of 20m from 2017
  • Rigel Pharmaceuticals Annual Total Assets for 2017 was $119m a 34.40% increase of 41m from 2016
Other Balance Sheet Metrics:
  • Rigel Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a 91.46% increase of 1m year over year
  • Rigel Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $103m a 2.73% increase of 3m year over year
View Chart On Koyfin

Quarterly RIGL Total Assets Data

09/2020$123m
06/2020$138m
03/2020$143m
12/2019$148m
09/2019$156m
06/2019$156m
03/2019$173m
12/2018$139m
09/2018$123m
06/2018$141m

Annual RIGL Total Assets Data

2019$148m
2018$139m
2017$119m
2016$78m
2015$132m
2014$154m
2013$226m
2012$310m
2011$257m
2010$187m